ChromoGenics postpones publication of the financial report for the third quarter in 2023
The Board of Directors of ChromoGenics has decided to postpone the publication of the financial report for the third quarter in 2023.
For practical reasons, the Board of Directors of ChromoGenics has decided to postpone the publication of the third quarterly report in 2023 until the 30th of November 2023. Previously communicated date for submission of the report was on the 23rd of November 2023.
Contact:
Fredrik Fränding, CEO
Anne-Marie Gullman, CFO & Head of Investor Relations
Tel: +46 (0) 18 430 0430
E-mail: [email protected]
ChromoGenics
This information was submitted, through the care of the above contact person, for publication on 21 November 2023 at 08:30 CEST.
This statement has been made in a Swedish and English version. In the event of any discrepancies between the Swedish and English text, the Swedish text shall prevail.
About ChromoGenics
ChromoGenics is a proptech company producing smart dynamic glass that improves indoor environments and well-being and lowers buildings’ energy consumption, operating expenses and impact on the climate. The company’s product ConverLight® Dynamic is based on a unique patented technology from the Ångström Laboratory in Uppsala, where electrochromic coatings are sputtered onto plastic film. The result is a dynamic film that can be laminated between glass layers, which provides buildings with good solar protection and lowered environmental impact from production, transport and use. The dynamic film is easy to transport and can be applied by local partners in the glass industry, which means it is possible to avoid long-distance shipping of bulky glass. All of ChromoGenics’ products strive to follow the key words environment and health. This means a focus on environmentally friendly material, lower energy consumption, increased access to daylight and views and improved indoor comfort.
The company’s production facilities in Uppsala have been financed in part by a conditional loan from the Swedish Energy Agency. ChromoGenics’ share (CHRO) is listed on Nasdaq First North Growth Market, and Vator Securities is the Certified Adviser.
